1 - 25 of 109 results for author:"Huber M." in Literature citations
Results Customize
› Repeat search in UniProtKB (57)
| Unlike alphabeta T cells, gammadelta T cells, LTi cells and NKT cells do not require IRF4 for the production of IL-17A and IL-22. Raifer H., Mahiny A.J., Bollig N., Petermann F., Hellhund A., Kellner K., Guralnik A., Reinhard K., Bothur E., Huber M. et al. Eur. J. Immunol. 42:3189-3201(2012) · Mapped (12) |
| Neuroinflammation by cytotoxic T-lymphocytes impairs retrograde axonal transport in an oligodendrocyte mutant mouse. Ip C.W., Kroner A., Groh J., Huber M., Klein D., Spahn I., Diem R., Williams S.K., Nave K.A., Edgar J.M. et al. PLoS ONE 7:e42554-e42554(2012) · Mapped (2) |
| Transcription factor IRF4 determines germinal center formation through follicular T-helper cell differentiation. Bollig N., Brustle A., Kellner K., Ackermann W., Abass E., Raifer H., Camara B., Brendel C., Giel G., Bothur E. et al. Proc. Natl. Acad. Sci. U.S.A. 109:8664-8669(2012) · Mapped (7) |
| The clinical impact of DNA methylation frequencies of JAK2 negative regulators in patients with essential thrombocythemia. Fodermayr M., Zach O., Huber M., Machherndl-Spandl S., Wolfl S., Bosmuller H.C., Hasenschwandtner S., Burgstaller S., Krieger O., Lutz D. et al. Leuk. Res. 36:588-590(2012) · Mapped (6) |
| The SH2-domain of SHIP1 interacts with the SHIP1 C-terminus: impact on SHIP1/Ig-alpha interaction. Mukherjee O., Weingarten L., Padberg I., Pracht C., Sinha R., Hochdorfer T., Kuppig S., Backofen R., Reth M., Huber M. Biochim. Biophys. Acta 1823:206-214(2012) · Mapped (7) |
| c-Rel promotes type 1 and type 17 immune responses during Leishmania major infection. Reinhard K., Huber M., Wostl C., Hellhund A., Toboldt A., Abass E., Casper B., Joeris T., Herr C., Bals R. et al. Eur. J. Immunol. 41:1388-1398(2011) · Mapped (2) |
| A proton-detected 4D solid-state NMR experiment for protein structure determination. Huber M., Hiller S., Schanda P., Ernst M., Bockmann A., Verel R., Meier B.H. Chemphyschem 12:915-918(2011) · Mapped (1) |
| Absence of TRIF signaling in lipopolysaccharide-stimulated murine mast cells. Keck S., Muller I., Fejer G., Savic I., Tchaptchet S., Nielsen P.J., Galanos C., Huber M., Freudenberg M.A. J. Immunol. 186:5478-5488(2011) · Mapped (24) |
| Homeodomain-only protein HOP is a novel modulator of late differentiation in keratinocytes. Obarzanek-Fojt M., Favre B., Kypriotou M., Ryser S., Huber M., Hohl D. Eur. J. Cell Biol. 90:279-290(2011) · Mapped (3) |
| The TRAF-interacting protein (TRIP) is a regulator of keratinocyte proliferation. Almeida S., Ryser S., Obarzanek-Fojt M., Hohl D., Huber M. J. Invest. Dermatol. 131:349-357(2011) · Mapped (6) |
| Human endothelial and platelet septin SEPT11: cloning of novel variants and characterisation of interaction partners. Bartsch I., Blaser S., Roseler S., Sandrock K., Busse A., Huber M., Rempp H., Lieber M., Horn J., Brendle C. et al. Thromb. Haemost. 104:1201-1210(2010) · Mapped (3) |
| Role of CYP2C9 genetic variants for salt sensitivity and the regulation of the renin-angiotensin-aldosterone system in normotensive men. Bolbrinker J., Beige J., Huber M., Sharma A.M., Thomas A., Deter H.C., Kreutz R. J. Hypertens. 29:56-61(2011) · Mapped (7) |
| I787 provides signals for c-Kit receptor internalization and functionality that control mast cell survival and development. Orinska Z., Foger N., Huber M., Marschall J., Mirghomizadeh F., Du X., Scheller M., Rosenstiel P., Goldmann T., Bollinger A. et al. Blood 116:2665-2675(2010) · Mapped (6) |
| Role of the angiotensin II type 2 receptor gene (+1675G/A) polymorphism on left ventricular hypertrophy and geometry in treated hypertensive patients. Huber M., Voller H., Jakob S., Reibis R., Do V., Bolbrinker J., Zergibel I., Schmieder R.E., Treszl A., Wegscheider K. et al. J. Hypertens. 28:1221-1229(2010) · Mapped (1) |
| Activation of murine macrophages via TLR2 and TLR4 is negatively regulated by a Lyn/PI3K module and promoted by SHIP1. Keck S., Freudenberg M., Huber M. J. Immunol. 184:5809-5818(2010) · UniProtKB (1) · Mapped (11) |
| NF-kappaB promotes epithelial-mesenchymal transition, migration and invasion of pancreatic carcinoma cells. Maier H.J., Schmidt-Strassburger U., Huber M.A., Wiedemann E.M., Beug H., Wirth T. Cancer Lett. 295:214-228(2010) · Mapped (1) |
| c-Rel is crucial for the induction of Foxp3(+) regulatory CD4(+) T cells but not T(H)17 cells. Visekruna A., Huber M., Hellhund A., Bothur E., Reinhard K., Bollig N., Schmidt N., Joeris T., Lohoff M., Steinhoff U. Eur. J. Immunol. 40:671-676(2010) · Mapped (14) |
| Overlapping functions of nuclear envelope proteins NET25 (Lem2) and emerin in regulation of extracellular signal-regulated kinase signaling in myoblast differentiation. Huber M.D., Guan T., Gerace L. Mol. Cell. Biol. 29:5718-5728(2009) · Mapped (17) |
| Steel factor enhances supraoptimal antigen-induced IL-6 production from mast cells via activation of protein kinase C-beta. Fehrenbach K., Lessmann E., Zorn C.N., Kuhny M., Grochowy G., Krystal G., Leitges M., Huber M. J. Immunol. 182:7897-7905(2009) · Mapped (6) |
| Requirement for CD45 in fine-tuning mast cell responses mediated by different ligand-receptor systems. Grochowy G., Hermiston M.L., Kuhny M., Weiss A., Huber M. Cell. Signal. 21:1277-1286(2009) · Mapped (7) |
| Loss-of-function mutations of an inhibitory upstream ORF in the human hairless transcript cause Marie Unna hereditary hypotrichosis. Wen Y., Liu Y., Xu Y., Zhao Y., Hua R., Wang K., Sun M., Li Y., Yang S., Zhang X.J. et al. Nat. Genet. 41:228-233(2009) · UniProtKB (1) |
| IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Huber M., Brustle A., Reinhard K., Guralnik A., Walter G., Mahiny A., von Low E., Lohoff M. Proc. Natl. Acad. Sci. U.S.A. 105:20846-20851(2008) · Mapped (6) |
| Bruton's tyrosine kinase is dispensable for the Toll-like receptor-mediated activation of mast cells. Zorn C.N., Keck S., Hendriks R.W., Leitges M., Freudenberg M.A., Huber M. Cell. Signal. 21:79-86(2009) · Mapped (2) |
| Enhanced B-cell activation mediated by TLR4 and BCR crosstalk. Minguet S., Dopfer E.P., Pollmer C., Freudenberg M.A., Galanos C., Reth M., Huber M., Schamel W.W. Eur. J. Immunol. 38:2475-2487(2008) · Mapped (4) |
| Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling. Malanchi I., Peinado H., Kassen D., Hussenet T., Metzger D., Chambon P., Huber M., Hohl D., Cano A., Birchmeier W. et al. Nature 452:650-653(2008) · Mapped (24) |